Lupin, headquartered in Mumbai, India, is a global pharmaceutical player with products distributed in over 100 markets ...

Lupin today announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1 manufacturing facility that ...

Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.

McDonalds’s joins the growing list of companies revising DEI policies. McDonald's is putting the emphasis on inclusion and ...

The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...